DEVICE CATEGORY · QWT
Prognostic Assessment Software Of Mild Cognitive Impairment
Prognostic assessment software of mild cognitive impairment. Prognostic assessment software of mild cognitive impairment is a prescription-only device that combines information from multiple clinical data sources to produce an output indicative of the likelihood that a patient diagnosed with mild cognitive impairment will progress to more severe forms of cognitive impairment, or will develop dementia, such as Alzheimers disease dementia, within a specified period of time. This device is intended for adjunctive use and not intended as a stand-alone diagnostic or prognostic too.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NEXT-CueK261805 | Neuroxt, Inc. | 510(k) clearance | Oct 8, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
